Filters

Miz1/ZNF60 Antibody, FITC Conjugated

Miz1/ZNF60 Antibody, FITC Conjugated size: 0.1ml 333

Supplier BIOSS PRIMARY CONJUGATED ANTIBODIES 1
Price 333
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long name FITC Conjugated, Miz1/ZNF60 Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationAnti-FITC Antibody
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenMiz1/ZNF60
SpecificityThis is a highly specific antibody against Miz1/ZNF60
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
SourceKLH conjugated synthetic peptide derived from human Miz1/ZNF60
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background A POZ domain Zn finger protein, Expression of Miz-1 induces potent growth arrest function, Miz-1 associates with DNA elements on the adenovirus major late and cyclin D1 promoters and activates transcription of both promoters, Miz-1 interacts with Myc, N-Myc- and L-Myc, The c-Myc protein activates transcription as part of a heteromeric complex with a number of interacting partners, and binding of Myc to Miz-1 requires the helix-loop-helix domain of Myc and a short amphipathic helix located in the carboxy-terminus of Miz-1, and this latency is reversed by the addition of Myc, apoptosis and transformation, are nuclear proteins with relatively short half lives that contribute an important role in cellular processes such as proliferation, but not Max or other Myc partners, designated Miz-1 for Myc-interacting Zn finger protein-1, differentiation, however the transforming properties of the Myc proto-oncogene are believed to be associated with Myc-mediated transcriptional repression, including Max and Mxi 1, including c-Myc-, is a specific target of Myc-induced gene repression, The Myc family
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission494nm/518nm
Synonyms MIZ1 pHZ-67
Properties Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
Gene targetMiz1/ZNF60 Conjugated
Short name FITC Conjugated, Miz1/ZNF60 Antibody
Technique Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelFITC
Alternative name fluorecein coupled, Miz1/ZNF60 (Antibody to)
Alternative techniqueantibodies
Identity 12936
Gene ZBTB17
Long gene name zinc finger and BTB domain containing 17
Synonyms gene ZNF151 ZNF60
Synonyms gene name zinc finger protein 151 (pHZ-67) zinc finger protein 60
Locus 1p36, 13
Discovery year 1994-03-16
GenBank acession U20647
Entrez gene record 7709
RefSeq identity NM_003443
Classification BTB domain containing Zinc fingers C2H2-type
Havana BLAST/BLAT OTTHUMG00000009377

Similar products

Subscribe to our Newsletter